Atlas Trials

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

Clinical trial NCT01203631 · COMPLETED

Trial details

NCT number
NCT01203631
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
InflammationCrohn's Disease
Start date
2011-02-01
Primary completion
2013-05-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.